[2]
Digiuni M,Fogagnolo P,Rossetti L, A review of the use of latanoprost for glaucoma since its launch. Expert opinion on pharmacotherapy. 2012 Apr; [PubMed PMID: 22348427]
[3]
Radell JE,Serle JB, Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension. Drugs of today (Barcelona, Spain : 1998). 2019 Sep; [PubMed PMID: 31584573]
[4]
Ocklind A, Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections. Experimental eye research. 1998 Aug; [PubMed PMID: 9733584]
[5]
Lindsey JD,Gaton DD,Sagara T,Polansky JR,Kaufman PL,Weinreb RN, Reduced TIGR/myocilin protein in the monkey ciliary muscle after topical prostaglandin F(2alpha) treatment. Investigative ophthalmology [PubMed PMID: 11431442]
[6]
Camras CB,Bito LZ,Eakins KE, Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Investigative ophthalmology [PubMed PMID: 924742]
[7]
Lindén C,Alm A, Latanoprost twice daily is less effective than once daily: indication of receptor subsensitivity? Current eye research. 1998 Jun [PubMed PMID: 9663846]
[8]
Alm A,Stjernschantz J, Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 1995 Dec; [PubMed PMID: 9098273]
[9]
Li T,Lindsley K,Rouse B,Hong H,Shi Q,Friedman DS,Wormald R,Dickersin K, Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis. Ophthalmology. 2016 Jan; [PubMed PMID: 26526633]
[10]
Rácz P,Ruzsonyi MR,Nagy ZT,Gaygi Z,Bito LZ, Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol. Archives of ophthalmology (Chicago, Ill. : 1960). 1996 Mar; [PubMed PMID: 8600885]
[12]
Belkin A,Chen T,DeOliveria AR,Johnson SM,Ramulu PY,Buys YM,American Glaucoma Society and the Canadian Glaucoma Society., A Practical Guide to the Pregnant and Breastfeeding Patient with Glaucoma. Ophthalmology. Glaucoma. 2020 Mar - Apr; [PubMed PMID: 32672600]
[14]
Kahook MY,Noecker R, Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Advances in therapy. 2008 Aug; [PubMed PMID: 18670744]
[15]
Grierson I,Jonsson M,Cracknell K, Latanoprost and pigmentation. Japanese journal of ophthalmology. 2004 Nov-Dec [PubMed PMID: 15592791]
[16]
Holló G,Aung T,Cantor LB,Aihara M, Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: Mechanism, diagnosis, and management. Survey of ophthalmology. 2020 Sep - Oct [PubMed PMID: 32092363]
[17]
Villegas VM,Díaz L,Izquierdo NJ, Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report. Puerto Rico health sciences journal. 2008 Dec [PubMed PMID: 19069363]
[18]
Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost., Tokuda N,Kitaoka Y,Matsuzawa A,Tsukamoto A,Sase K,Sakae S,Takagi H,, Journal of ophthalmology, 2017 [PubMed PMID: 28831305]
[19]
Lee JH,Kim TH,Kim SC, Allergic contact dermatitis caused by topical eye drops containing latanoprost. Annals of dermatology. 2014 Apr [PubMed PMID: 24882991]
[20]
Bitner DP,Freedman SF, Long-term home monitoring of intraocular pressure in pediatric glaucoma. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2016 Dec [PubMed PMID: 27702611]
[21]
Tressler CS,Wiseman RL,Dombi TM,Jessen B,Huang K,Kwok KK,Wirostko BM, Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature. The British journal of ophthalmology. 2011 Nov; [PubMed PMID: 21515566]
[22]
Parrish RK,Palmberg P,Sheu WP, A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. American journal of ophthalmology. 2003 May [PubMed PMID: 12719078]